Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Consolidated Net Income: 2013-2017

Historic Consolidated Net Income for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to -$544,000.

  • Soleno Therapeutics' Consolidated Net Income rose 54.35% to -$544,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.6 million, marking a year-over-year increase of 52.99%. This contributed to the annual value of -$175.8 million for FY2024, which is 353.15% down from last year.
  • Soleno Therapeutics' Consolidated Net Income amounted to -$544,000 in Q4 2017, which was up 57.96% from -$1.3 million recorded in Q3 2017.
  • In the past 5 years, Soleno Therapeutics' Consolidated Net Income registered a high of -$544,000 during Q4 2017, and its lowest value of -$4.3 million during Q1 2016.
  • In the last 3 years, Soleno Therapeutics' Consolidated Net Income had a median value of -$1.3 million in 2016 and averaged -$1.9 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 379.25% in 2014, then soared by 80.25% in 2017.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Consolidated Net Income stood at -$869,278 in 2013, then plummeted by 379.25% to -$4.2 million in 2014, then climbed by 15.85% to -$3.5 million in 2015, then spiked by 66.01% to -$1.2 million in 2016, then soared by 54.35% to -$544,000 in 2017.
  • Its last three reported values are -$544,000 in Q4 2017, -$1.3 million for Q3 2017, and -$913,000 during Q2 2017.